Plain-English translation of NCT06259019 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called the Liquid Biopsy System that collects small blood samples directly from your diseased heart arteries during a cardiac procedure you're already scheduled to have. By analyzing these blood samples, researchers hope to discover important clues about what's happening in your arteries and eventually develop better personalized treatments for coronary artery disease.
Doctors need better ways to understand what's actually happening inside diseased coronary arteries so they can develop more targeted treatments. This trial aims to fill that knowledge gap by collecting and analyzing blood samples directly from the problem areas in your heart.
You likely qualify if…
You likely don't qualify if…
If you qualify, during your already-scheduled heart imaging procedure, doctors will use the Liquid Biopsy System device to collect a small blood sample directly from your diseased artery. This happens at the same time as your routine imaging and heart treatment, so it doesn't require extra visits or procedures. The blood samples are then analyzed in the laboratory to help researchers understand disease patterns and develop better treatments.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United Kingdom